ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,765.11
      0.92%
      US Tech 100
      19,646.40
      1.06%
      Dow Jones
      42,099.92
      0.73%
      Brent Oil
      76.035
      1.22%
      Bitcoin
      70,046.43
      3.28%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Transgene SA (TNG) Quote

      Transgene SA

      Transgene SA (TNG)

      Tng Limited
      Tong Ren Tang Technologies Co
      0.914
      -0.008
      ( -0.87% )
      Updated: 11:28:21
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.914
      Bid
      0.902
      Ask
      0.915
      Volume
      47,904
      0.899 Day's Range 0.964
      0.834 52 Week Range 1.54
      Market Cap
      92.179M
      Previous Close
      0.922
      Open
      0.938
      Last Trade
      691
      @
      0.914
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      33,195
      Shares Outstanding
      100,852,742
      Dividend Yield
      -
      PE Ratio
      -4.11
      Earnings Per Share (EPS)
      -0.22
      Revenue
      7.9M
      Net Profit
      -22.33M

      About Transgene SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.transgene.fr
      Headquarters
      Illkirch-graffenstaden, Bas-rhin, Fra
      Founded
      -
      Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 0.92 €. Over the last year, Transgene shares have traded in a share price range of 0.834 € to 1.54 €.

      Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 92.99 € million. Transgene has a price to earnings ratio (PE ratio) of -4.11.

      Ask ADVFN Intelligence (AI)

      TNG Latest News

      More News

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a...

      10 hours ago
      UK Regulatory

      Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

      Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

      10 hours ago
      UK Regulatory

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

      Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

      10 hours ago
      GlobeNewswire Inc.

      Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques

      Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques Les premiers résultats...

      October 14 2024
      UK Regulatory

      Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

      Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Top line data show that the randomized...

      October 14 2024
      UK Regulatory

      Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

      Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab alone in patients with recurrent or metastatic HPV16-positive cervical and anogenital...

      October 14 2024
      GlobeNewswire Inc.

      Transgene présentera un poster sur les données actualisées de TG4050 au SITC 2024

      Transgene présentera un poster sur les données actualisées de TG4050 au SITC 2024 Transgene présentera le suivi médian à 24 mois des patients del'essai de Phase I évaluant le vaccin thérapeutique...

      October 07 2024
      UK Regulatory

      Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024

      Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024 Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the...

      October 07 2024
      UK Regulatory

      Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024

      Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the individualized cancer vaccine TG4050 in the adjuvant treatment of head and neck...

      October 07 2024
      GlobeNewswire Inc.

      Transgene prévoit d’importants résultats cliniques d’ici fin 2024 et confirme sa visibilité financière jusqu’au 4ème trimestre 2025

      Transgene prévoit d’importants résultats cliniques d’ici fin 2024 et confirme sa visibilité financière jusqu’au 4ème trimestre 2025 Résultats financiers du 1er semestre 2024 et point sur...

      September 24 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0627.276995305160.8520.9640.837205980.88772989DE
      4-0.196-17.65765765771.111.20.834464930.98860174DE
      12-0.09-8.964143426291.0041.210.834331951.04949418DE
      26-0.334-26.76282051281.2481.350.834285381.10686275DE
      52-0.602-39.7097625331.5161.540.834283391.20443899DE
      156-1.501-62.15320910972.4152.990.834387771.96666018DE
      260-0.886-49.22222222221.83.150.81743801.98945673DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALACTActicor Biotech
      0.59 €
      (31.11%)
      		45.33k
      EBUSEbusco Holding NV
      3.5795 €
      (30.61%)
      		887.83k
      ALREARealites
      2.52 €
      (26.63%)
      		40.32k
      TAYNTayninh
      1.47 €
      (21.49%)
      		9
      DMSBSDiagnostic Medical Systems
      0.003 €
      (20.00%)
      		50
      ALNEVNeovacs
      0.0002 €
      (-33.33%)
      		18.95M
      TMBSZTME Pharma NV
      0.02 €
      (-33.33%)
      		33.4k
      ALSRSSirius Media
      0.0157 €
      (-32.91%)
      		2.26M
      MLFTIFrance Tourisme Immobilier
      0.0345 €
      (-21.59%)
      		5.05k
      LIGLisgrafica
      0.002 €
      (-20.00%)
      		581.55k
      BCPBanco Comercial Portugues SA
      0.454 €
      (0.67%)
      		41.49M
      ALHPIHopium SA
      0.0112 €
      (1.82%)
      		29.43M
      ALNEVNeovacs
      0.0002 €
      (-33.33%)
      		18.95M
      ALNRGEnergisme SA
      0.006 €
      (-7.69%)
      		18.12M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		15.56M

      Discussion

      View Full Feed
      ChannelTrader ChannelTrader 41 seconds ago
      I think Trump is going to win.
      100lbStriper 100lbStriper 41 seconds ago
      cool.........but my patience is already toast!!! lol!!!
      NLST
      Trooperstocks Trooperstocks 1 minute ago
      $ILLR $3.25 +15.55% #talkcapabilities
      https://pbs.twimg.com/media/Gboge9LbgAA6Ndx?format=png&name=900x900
      ILLR
      getmoreshares getmoreshares 1 minute ago
      hope he rescinds the SS change--- Many name and SS changes have been denied on various positions. One holding filed for a name change over a year ago- still has not happened.
      CGAC
      Trooperstocks Trooperstocks 2 minutes ago
      $ILLR $3.25 +15.55% #talkcapabilities
      https://pbs.twimg.com/media/Gboge9LbgAA6Ndx?format=png&name=900x900
      ILLR
      twitchy twitchy 2 minutes ago
      Hopefully stronger hands on the next push will surge YUKA to new highs.
      YUKA
      SorcererDiviner18 SorcererDiviner18 2 minutes ago
      INSTITIONAL INVESTOR.

      WANTS SOME EQUITY.

      LETS GO.

      GOODBYE TOXIC LENDING.
      BEGI
      powerbattles powerbattles 2 minutes ago
      WOW! .0025. I just took one more screenshot. This is beyond criminal. SS undated. OTCN can't scare anybody now.
      AFFU
      Hoghead7 Hoghead7 2 minutes ago
      47M shares traded yesterday by 10.40am. 21M today at 11.40am. Massive difference. Should hold $.36 although would have been nice to hold $.37
      FCEL
      STOCKMONSTER STOCKMONSTER 3 minutes ago
      1000 BUCKS PER SHARE WAS SO MUCH BETTER THAN RIGHT NOW!!!!!!!!!!!!!!!!!!!!!!!!!!! NVDA LOST ALL IT'S MOJO CHASING THE A.I. DREAM!!!!!!!!!! BLAHAHHAHAAH!!!!!!!!!!!!
      NVDA
      kund kund 3 minutes ago
      comment from Lane, only guy who was bullish on AVXL in SA: Aricept (donepezil) and blarcamesine are both likely sigma-1 receptor agonists.
      pubmed.ncbi.nlm.nih.gov/...
      The affinity of Aricept for sigma-1 receptors appears to be greater than that of blarcamesine, so it is possible that
      AVXL
      IronChefQuezon IronChefQuezon 3 minutes ago
      I never blame people for taking profits. I've done it elsewhere and missed out on bigger gains. It happens. Fundamentals are too good here for me though, and I think a lot of people agree. Volume here is still very low for an OTC stock so I think there are a lot of others, like us, who are holding t
      APRU
      I-Glow I-Glow 3 minutes ago
      It's the bigger fool theory of investing - pump it - rally is imminent - so they can dump on the bigger fool.

      IG
      GVSI
      236T568 236T568 3 minutes ago
      oops, 8/10 not 9/10

      sorry
      Think1st Think1st 3 minutes ago
      Lwlg up today 3.24
      Epd up today
      LWLG
      ge11 ge11 4 minutes ago
      Comment from a different board.

      just heard that the offering was a huge success and participants could only get a portion of their interest. That means they are not interested to raise any more than needed in foreseeable future. .
      NB
      EisMCA2 EisMCA2 4 minutes ago
      200 eggs per mated couple is saying that less than 2 thirds of the eggs are going to hatch. Very low. Also, it isn't a mated couple. 1 male can fertilize 12-15 females. But, even with your lower number of 55,000, if half are female, and they can each lay 300-350 eggs each, you are looking at 8.25 mi
      KBLB
      Sltan Sltan 4 minutes ago
      RNVA foxo RNVA foxo RNVA
      RNVA
      SkeBallLarry SkeBallLarry 4 minutes ago
      " Good morning, ForrestMan " .. !!
      Slojab Slojab 4 minutes ago
      He wouldn't waste his time on tweeting worthless info.

      But when worthless info is all you got .........
      BMCS
      $GROO $GROO 4 minutes ago
      Hey Mod's how about a logo change, hmmmmm?????? 55 days to go
      SANP
      georgeofthebungle georgeofthebungle 5 minutes ago
      https://www.otcmarkets.com/stock/RDAR/news/Raadr-Inc-Announces-Agreement-with-Shareholders-for-the-Cancellation-of-1
      RDAR

      Your Recent History

      EU
      TNG
      Transgene
      LSE
      72YE
      Affinity 5 7/8%
      TG
      RLF
      Longfor
      Delayed Upgrade Clock